BGB324, a small molecule inhibitor of Axl developed by Holland et al. [169], blocks Axl-dependent signaling events, reduces the EMT transcriptional regulator Snail, and inhibits angiogenesis and tumor formation [169]. This evidence concerns the gene AXL and neoplasm.